ASH Conference will hopefully have some good n... - CLL Support

CLL Support

22,532 members38,709 posts

ASH Conference will hopefully have some good news on CLL progress

17Pisme profile image
4 Replies

I am a patient of Dr. Jain at MDA (prior with Dr. O'Brien before she left for Irvine) and was in the early Ibrutinib/Rituxin study at MDA. I am currently on Venetoclax/Rituxin and was at MDA yesterday for my next to last Rituxin treatment. I had a great conversation with Dr. Jain, who is the lead in the IV trial at MDA and was extremely excited about the early results which he will share at the ASH Conference in San Diego the first week of December. He is equally excited about the conference and believes much good news will be shared at the event. Fingers crossed and let's be prepared to share some good news should it be forthcoming. Good luck to us all.

Written by
17Pisme profile image
17Pisme
To view profiles and participate in discussions please or .
4 Replies
Cllcanada profile image
CllcanadaTop Poster CURE Hero

Follow the link. Dr. Jain's abstract is the third or fourth down...

ash.confex.com/ash/2018/web...

cajunjeff profile image
cajunjeff

The abstracts are out for the ASH meeting and I think the one I attached is the study to which you refer. The IV combo looks very promising for sure.

ash.confex.com/ash/2018/web...

Justasheet1 profile image
Justasheet1

17pisme,

How do you like Dr Jain? I will see him next week for the first time. Thanks,

Jeff

17Pisme profile image
17Pisme in reply to Justasheet1

I like him. I loved Dr. O'Brian and was extremely sad to see her go (in fact I almost followed her but how do you leave the quality of care of MDA). Dr. Jain was fine, it was me that had to take on a new attitude with the change. His assistant Victoria is fantastic as well (she takes care of business, which takes stress off of you). I would suggest that you do your homework , write down your questions and always take notes. He enjoys an educated patient as he should (I had to learn that).

You may also like...

Some good news and hope

able to access a clinical trial in the UK and in 2014 started a drug Ibrutinib which targets the...

Breaking news form ASH conference: looks like Ibrutinib May be better than FCR for some patients

#ASH18 #LBA | A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy Vs. Standard...

COVID and CLL -- A little good news

positive for COVID last week. And here is where the good news comes in. I have pretty much had no...

Good News of my CLL

more good news on CLL from Dr. Byrd out of Ohio State. My clone that is resistant to ibrutinib had...

ASH 2012 Ibrutinib Press Conference